Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Amcil Limited (AMH.AX)
Melbourne, VIC, AU
Amcil Limited operates as a publicly listed investment management firm. Its core business involves constructing and overseeing distinct equity portfolios tailored to individual client needs. The company primarily focuses its investments on the Australian public stock exchanges. To build these portfolios, it strategically allocates capital across both established large-capitalization and emerging small-capitalization companies, seeking opportunities in both growth and value-oriented equities. Established in 1996, Amcil Limited has its headquarters situated in Melbourne, Australia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.12% | +0.00% | -2.17% | -2.70% | -14.29% | -10.89% | -17.43% | -9.09% | -21.74% | -4.76% | +134.38% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-03 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Asset Management: +17.4%-5.4% Q4'25: +5.4% (vs Q4'23)
-
EPS growth Asset Management: +22.7%-11.3% Q4'25: -0.8% (vs Q4'23)
-
FCF margin FCF growth · Asset Management: +27.7%+69.6% Q4'25: +71.6% (vs Q4'23)
-
EBIT margin Asset Management: +50.6%+75.9% ★ Q4'25: +83.8% (vs Q4'23)
-
ROIC Asset Management: +6.5%+2.0% Q4'25: +5.5% (vs Q4'23)
-
Share dilution Asset Management: +0.0%+0.7% Q4'25: +1.2% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Asset Management: -0.03×— Q4'25: 0.00× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-28 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-27 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-26 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-25 | B- | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-22 | B- | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-21 | B- | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-20 | B- | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-19 | B- | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-18 | B- | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-15 | B- | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-14 | B- | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-13 | B- | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-12 | B- | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-11 | B- | 2/5 | 3/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | B- | 3/5 | 3/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | B- | 3/5 | 3/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | B- | 3/5 | 3/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-05 | B- | 3/5 | 3/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-01 | B- | 3/5 | 3/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | B- | 3/5 | 3/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | B- | 3/5 | 3/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B- | 3/5 | 3/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Andrew J. Porter | Chief Financial Officer & Company Secretary | — | male |
| Geoffrey N. Driver Ec | General Manager of Business Development & Investor Relations | — | male |
| Gilbert Battistella | Investment Analyst | — | male |
| Jaye Guy | Investment Analyst | — | male |
| Kieran Kennedy | Portfolio Manager | — | male |
| Matthew John Rowe AGIA ACIS | Company Secretary | — | male |
| Olga Kosciuczyk | Investment Analyst | — | female |
| Robert Mark Freeman | MD, Chief Executive Officer & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AMH.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
